Comparing Beovu vs Lucentis
Beovu | Lucentis |
|
---|
Beovu (brolucizumab) | Lucentis (ranibizumab) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Macular Degeneration, Diabetic Macular Edema. Beovu may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Macular Degeneration, Macular Edema Following Retinal Vein Occlusion , Diabetic Macular Edema, Macular Edema, Myopic Choroidal Neovascularization, Diabetic Retinopathy. Lucentis may... View more |
Related suggestions Macular Degeneration
Popular comparisons
|
|||||||||||||||
More about Beovu (brolucizumab) | More about Lucentis (ranibizumab) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Beovu has an average rating of 7.0 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Lucentis has an average rating of 6.5 out of 10 from a total of 15 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: Beovu side effects in more detail. |
See also: Lucentis side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Beovu prices |
View all Lucentis prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
Other ranibizumab brands include: Byooviz, Cimerli, Susvimo | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
105.6 hours |
216 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 1 drugs are known to interact with Lucentis:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
First Approval Date | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.